Ad Banner

World Economies Join Coronavirus Vaccine Acquisition Mechanism to Help Fight Pandemic

 

Economies around the world formally join the COVID-19 vaccine global acquisition mechanism to help the world fight the Epidemic

The 64 higher-income economies have already joined the COVID-19 vaccine global access mechanism, and another 38 economies are expected to sign up in the next few days.

These self-funded economies (including the 29 economies participating in the “European Team” as part of the agreement with the European Commission) will be in line with 92 countries eligible to receive financial support through the GAVI COVID-19 vaccine advance market commitment. Income economies join hands.

This means that a total of 156 economies (accounting for nearly two-thirds of the global population) are currently committed or eligible to receive vaccines through the global access mechanism. Click here to view the list of participating economies.


Which high income economies have joined GAVI?

64 high-income economies have joined the COVID-19 vaccine global access mechanism. This global initiative brings together governments and manufacturers to ensure that the COVID-19 vaccine is finally available to those who need it most, no matter who they are or where they are. 

The 64 companies include 35 economies and the European Commission, which will purchase vaccines on behalf of the 27 EU member states as well as Norway and Iceland.

By pooling financial and scientific resources, these participating economies will be able to ensure that they are protected from the failure of any vaccine candidates and obtain successful vaccines in a cost-effective and targeted manner.

 

Are Low Income Countries also included in GAVI?

In addition to these 64 members, the global access mechanism will also cover 92 low-income and middle-income economies that are eligible for vaccine procurement support through the Global Alliance for Vaccines and Immunization COVID-19 vaccine pre-market commitment.

 These countries are financing tools for purchasing vaccines. This means that 156 economies, which account for about 64% of the world’s total population, have either committed to join the COVID-19 vaccine global access mechanism, or are eligible for its support, and there will be more in the future.

 

With the conclusion of the commitment agreement, the COVID-19 vaccine global access mechanism will now begin to sign formal agreements with vaccine manufacturers and development agencies as working partners in the vaccine field to ensure that sufficient doses are obtained to end the acute phase of the pandemic by the end of 2021.

 In addition, efforts are being made to raise funds for research and development and the advance market commitment of COVID-19 vaccines through the Global Alliance for Vaccines and Immunization to purchase vaccines for low-income countries.

 

Dr. Seth Berkley, CEO of the Global Alliance for Vaccines and Immunization, which is responsible for coordinating the global access mechanism for COVID-19 vaccines, said:

 "The access to COVID-19 vaccines is underway: governments from all continents have chosen to work together to not only guarantee vaccines for their people, And also to help ensure that vaccines are available to the most vulnerable people around the world. 

We today announced our commitment to the global access mechanism for COVID-19 vaccines and are also building a historic partnership with the industry. 

With these, once safe and effective vaccines are available , We have a better chance to end the acute phase of this pandemic."

 

Is COVID Vaccine Global Access part of vaccine pillar of COVID tool acceleration plan?

The COVID-19 vaccine global access mechanism is part of the vaccine pillar of the COVID-19 tool acceleration plan. It is jointly led by the Epidemic Prevention Innovation Alliance, the Global Alliance for Vaccines and Immunization, and the World Health Organization. Cooperation between foundations, the World Bank, civil society organizations and other institutions.

 

Once licensed and approved, the distribution of vaccines will be guided by the distribution framework issued by WHO today. The framework follows the principles of fair and equal access to ensure that participating economies will not be left behind. The WHO immunization strategy advisory expert group recently released a framework of values ​​to lay the foundation for subsequent guidance documents and vaccine use policies for target populations.

 

WHO Director-General Dr. Tedros said: “COVID-19 is an unprecedented global crisis that requires an unprecedented global response. Vaccine nationalism will only perpetuate the disease and delay the global recovery. Through the COVID-19 vaccine The joint efforts of the Global Access Mechanism are not charity. Controlling the pandemic and accelerating the global economic recovery is in the best interest of every country."

 

Now, the commitment of fully self-financing economies will release important funding and demand guarantees to expand production and ensure the number of vaccines required by the global access mechanism. The Epidemic Prevention Innovation Alliance is leading the research and development of COVID-19 vaccines, with the goal of developing at least three safe and effective vaccines for use by economies participating in the Global Access Mechanism. Currently, the Epidemic Prevention Innovation Alliance is supporting 9 candidate vaccines, of which 8 are undergoing clinical trials.

 

Dr. Richard Hatchett, CEO of the Epidemic Prevention Innovation Alliance, said: “The international community’s joint response to this pandemic is a landmark moment in the history of public health. The global spread of COVID-19 means that only through simultaneous fair access to rescue With the new COVID-19 vaccine of life, we can hope to end this pandemic. Countries come together in this way because they have the common goal and determination to end the acute phase of the pandemic. We must now play a role in the global response Vaccine manufacturers with essential roles work closely together to form the necessary agreements to achieve the core goal of global access to COVID-19 vaccines, which is to provide 2 billion doses of vaccine by the end of 2021. Today, for the benefit of everyone, we are moving towards this goal A big step forward."

 

The success of the global acquisition of COVID-19 vaccine depends not only on the participation of economies in the global acquisition mechanism and the commitment of vaccine manufacturers, but also on filling the key funding gap for vaccine research and development and the Global Alliance for Vaccines and Immunization COVID-19 vaccine advance market commitments. Support low-income economies to participate in global access mechanisms.

 

World Economies Join Coronavirus Vaccine Acquisition Mechanism to Help Fight Pandemic
World Economies Fighting COVID Pandemic

So far, governments, vaccine manufacturers (in addition to their own research and development), various organizations and individuals have pledged to provide 1.4 billion US dollars for vaccine research and development, but in addition to providing 300 million US dollars for WHO’s “solidarity” trial, they have also There is an urgent need for another 700-800 million U.S. dollars to continue related work.

 

The Global Alliance for Vaccines and Immunization COVID-19 vaccine advance market pledge has raised approximately US$700 million from sovereign donors, charities and the private sector, and the initial goal is to require US$2 billion in seed funding by the end of 2020. Funding this mechanism is essential to ensure that the ability to pay does not become a barrier to obtaining the COVID-19 vaccine. Given the unabated pandemic and its impact, lack of access to vaccines will leave most parts of the world unprotected.

 

The commitment agreement also requires the governments of higher-income countries to advance funds for reserve doses by October 9, 2020. These funds will be used to accelerate the expansion of vaccine production to ensure 2 billion doses of vaccine sufficient to vaccinate 1 billion people (assuming this vaccine needs to be vaccinated twice). Further details on these advance payments can be found in the introduction material of the Global Vaccine Alliance COVID-19 Vaccine Global Access Mechanism.

 

In addition to purchasing for participating economies, the global access mechanism will also maintain a buffer dose for emergency and humanitarian use.

 

Views of participating countries

Canadian Prime Minister Justin Trudeau said: "COVID-19 is causing serious health concerns to people all over the world. This is why Canada is committed to working with partners around the world to end this pandemic. Access to safety is fair, timely and affordable. An effective COVID-19 vaccine is essential to help protect people’s health. Canada supports the goals and principles of the COVID-19 vaccine global access mechanism and believes that it is the only global collective procurement mechanism for countries to cooperate on this major cause. China is Part of this important global response."

 

New Zealand’s Prime Minister Ardern said: “New Zealand’s commitment to the global access mechanism for the COVID-19 vaccine also supports other countries in obtaining the COVID-19 vaccine.”

 

Dr. Edwin G. Dikoloti, Minister of Health and Health of Botswana, said: “The idea of ​​global access to the COVID-19 vaccine and equal access to the COVID-19 vaccine regardless of ability to pay is not only a moral imperative, but also the only response to this pandemic. A pragmatic solution. Protecting everyone is the only way to return our world-our trade, tourism, travel, commerce-to normal. We urge countries that have not yet joined to join in. Let us work together to protect each other."

 

Ethiopia’s Minister of Health, Dr. Lia Tadesse, said: “Vaccinations can save lives. Investing in immunization infrastructure can help strengthen the health system. We have seen this time and time again in the process of working with the Global Alliance for Vaccines and Alliance partners. As part of the COVID-19 vaccine global access mechanism and advance market commitment, we can continue this work to protect our citizens and the world from the effects of COVID-19."

 

Ekaterine Tikaradze, Minister of Health of Georgia, said: "To promote global access to COVID-19 vaccines, the world is uniting, proving that we are stronger together and that we can overcome this pandemic. Georgia will join the global access mechanism for our citizens Provide the best access to safe vaccines. By doing so, we also ensure that health care workers and other high-risk groups around the world have access to these life-saving tools to help contain the pandemic so that everyone can recover and recover. reconstruction."

 

Dr. Basel Humoud Al-Sabah, Minister of Health of the State of Kuwait, said: “Joining the COVID-19 vaccine global access mechanism is not a difficult decision. This not only enables Kuwaiti citizens to obtain the COVID-19 vaccine, but also means that our friends and partners abroad also Access to vaccines. We need a global solution to deal with the global pandemic. We believe that the Global Access Mechanism is the solution."

 

Dag-Inge Ulstein, Norwegian Minister of International Development, said: “We believe that international cooperation and global efforts are the key. We must continue our efforts to obtain equitable access to vaccines, testing reagents and treatments. To overcome the COVID-19 pandemic, rich countries need to be fast And act boldly to provide vaccines and treatments to those who cannot afford to pay for themselves. With the commitment to the global access mechanism, we are moving in the right direction."

 

Dr. Ahmed Mohammed Obaid Al Saidi, Minister of Health of the Sultanate of Oman, said: “This is a very important initiative that can provide us with a path out of the acute phase of the pandemic and return to normal. For the benefit of all of us, I urge all those who have not yet joined Countries join in. Cooperation is much better than doing things independently."

 

Partner's comment

Mr. Sai D. Prasad, Chairman of the Network of Vaccine Manufacturers in Developing Countries, said: “The history of vaccines will be defined by our response to COVID-19. The Global Access Mechanism for COVID-19 Vaccines is the center of the global response. Companies are in the midst of vaccine development and production. At the forefront, billions of vaccines can be supplied in the next few years. The global access mechanism will have a major impact on the lives and livelihoods of all countries, and promote countries to speed up the return to normal. The network of vaccine manufacturers in developing countries cooperates fully with their partners to strengthen global public Hygiene mission, let no one be left behind."

 

Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers Associations said: "It is very encouraging to see so many countries move from negotiations to full commitments. Only when rich and poor countries are united can the global access mechanism work and achieve Fair access. Today, vaccine manufacturers with the unique skills and expertise to increase production capacity to unprecedented levels are ready to meet the challenge of providing 2 billion doses of the currently unknown COVID-19 vaccine. This is no easy task because it requires Doubled the existing capacity in record time. Today we have taken an important step forward, which is also a historic sign of solidarity. This solidarity enables us to end the acute phase of this pandemic; We are proud to participate in this unique effort to leave no one behind."

 

Jagan Chapagain, secretary-general of the International Federation of Red Cross and Red Crescent Societies, said: “We must work together through the COVID-19 vaccine global access mechanism to ensure that the COVID-19 vaccine is distributed and delivered to those who need it most, not just Only those who can afford it. We have a moral and public responsibility to protect the poor in rural communities, just like the rich in cities, the elderly in nursing homes, and the young in refugee camps. We humans The power of and the success of the global access mechanism will depend on how we work together to protect the most vulnerable among us."

 

Save the Children CEO Kevin Watkins said: "Global cooperation must become the cornerstone of the global response to COVID-19. The COVID-19 vaccine global access mechanism may help ensure universal and fair access to future COVID-19 vaccines. To do this On one point, we need to ensure that people in low- and middle-income countries get their share and get the vaccines they need to help overcome the greatest public health and child rights crisis facing our generation."

 

UNICEF Executive Director Henrietta Fore said: “Seeing that all parties are so united in the face of the COVID-19 crisis, we believe that we can work together to ensure the fair delivery of the COVID-19 vaccine globally. UNICEF’s supply chain With presence all over the world and staff in 190 countries, we are proud to support this historic effort."

 

Notes to the editor

Explanatory materials about the global access mechanism for the COVID-19 vaccine can be found on the website of the Global Alliance for Vaccines and Immunization, and the Q&A from Seth Berkley, CEO of the Global Alliance for Vaccines and Immunization, can be viewed here.

 

Complete self-financing economies that have submitted binding commitment agreements and non-binding confirmations of intent to participate, and 92 low- and middle-income countries eligible to join the Global Alliance for Vaccines and Immunization COVID-19 vaccine pre-market commitments The list can be found here.

 

About the Global Alliance for Vaccines

 

The Global Alliance for Vaccination and Immunization is a government-private partnership project to help half of the world’s children vaccinate to prevent some of the deadliest diseases. Since its establishment in 2000, the Global Alliance for Vaccines and Immunization has helped to vaccinate a whole generation, that is, more than 760 million children, avoid more than 13 million deaths, and help halve child mortality in 73 developing countries. The Global Alliance for Vaccines and Immunization also supports the health system and funds global stockpiles of vaccines for Ebola, cholera, meningitis and yellow fever, thus playing a key role in improving global health security. After 20 years of progress, the Global Alliance for Vaccines and Immunization is now committed to protecting the next generation, helping unvaccinated children who are left behind, using innovative financing methods and the latest technologies from drones to biometrics to save millions of lives , To prevent outbreaks before they spread, and to help countries embark on a path of self-sufficiency. Learn more on www.gavi.org and connect with us on Facebook and Twitter.

 

The Global Alliance for Vaccines and Immunization brings together developing and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical institutions, civil society, the Bill and Melinda Gates Foundation and other private sector partners. Click here to see the full list of donor governments and other major organizations that fund the work of the Global Alliance for Vaccines and Immunization.

 

About Epidemic Prevention Innovation Alliance

 

The Epidemic Prevention Innovation Alliance is an innovative partnership between public, private, charitable and civil organizations launched in Davos in 2017 to develop vaccines to prevent future epidemics. In response to the COVID-19 epidemic, the Epidemic Prevention Innovation Alliance took urgent action and coordinated with the WHO. The Epidemic Prevention Innovation Alliance has initiated nine partnerships to develop a new coronavirus vaccine. These plans are taking advantage of the rapid response platforms and new partnerships that the alliance already supports.

 

Prior to the COVID-19 outbreak, the top diseases that the Epidemic Prevention Innovation Alliance focused on included Ebola virus, Lassa virus, Middle East respiratory syndrome coronavirus, Nipah virus, Rift Valley fever and Chikungunya virus. The Epidemic Prevention Innovation Alliance has also invested in platform technologies that can be used for rapid vaccine and immune prevention development against unknown pathogens (Disease X).

 

About the World Health Organization

The World Health Organization plays a global leadership role in the field of public health within the United Nations system. Founded in 1948, WHO has more than 150 offices around the world, working with 194 member states from six regions to promote health, keep the world safe, and serve vulnerable groups. Our goal for 2019-2023 is to ensure that one billion more people will benefit from universal health coverage, one billion more people will be better protected in the face of health emergencies, and one billion more people will have improved health and well-being.

 

To learn more about COVID-19 and public health advice to protect yourself from the coronavirus, please visit www.who.int/zh and follow on Twitter, Facebook, Instagram, LinkedIn, TikTok, Pinterest, Snapchat and YouTube WHO.

 

Regarding the Acceleration Plan for Access to COVID-19 Tools

 

The Acceleration Program for Access to COVID-19 Tools is a pioneering new global cooperation initiative aimed at accelerating the development, production, and fair access to COVID-19 testing methods, treatments, and vaccines. In April 2020, WHO, the European Commission, France and the Bill and Melinda Gates Foundation jointly initiated the establishment in response to the call of the leaders of the G20.

 

The Acceleration Plan for Access to COVID-19 Tools is not a decision-making body or a new organization, but is dedicated to accelerating collaborative efforts between existing organizations to end the pandemic. This is a collaborative framework that aims to enable key actors to work together through accelerated development, fair distribution, and expanded delivery of test kits, treatments, and vaccines to end the pandemic as soon as possible, thereby protecting the health system and restoring it in the near future Society and economy. It draws on the leading experience of the Global Health Organization, which is responding to the world’s toughest health challenges. Through joint efforts, these organizations can achieve more ambitious new results against COVID-19. The participating members jointly pledge to ensure that everyone has access to all the tools needed to defeat COVID-19, and work together to achieve this goal in an unprecedented partnership.

 

The Acceleration Program for Acquiring COVID-19 Tools has four areas of work: diagnostic methods, treatment methods, vaccines, and connection to the health system. The workflow for acquisition and distribution is cross-cutting.   




May Refer also:



Post a comment

0 Comments